Skip to main content
Top
Published in: BMC Complementary Medicine and Therapies 1/2017

Open Access 01-12-2017 | Research article

Anti-Hyperuricemic, Anti-Inflammatory and Analgesic Effects of Siegesbeckia orientalis L. Resulting from the Fraction with High Phenolic Content

Authors: Thuy Duong Nguyen, Phuong Thien Thuong, In Hyun Hwang, Thi Kim Huyen Hoang, Minh Khoi Nguyen, Hoang Anh Nguyen, MinKyun Na

Published in: BMC Complementary Medicine and Therapies | Issue 1/2017

Login to get access

Abstract

Background

The medicinal plant Siegesbeckia orientalis L. has been commonly used for the treatment of acute arthritis, rheumatism, and gout in Vietnam. However, pharmacological research of this plant associated with gout has not been reported. Anti-hyperuricemic and anti-inflammatory effects were evaluated and observed for the crude ethanol extract (CEE) of S. orientalis. Retention of these biological properties was found in a n-butanol-soluble fraction (BuOH fr.) of the extract, and therefore further biological and chemical investigations were undertaken on the BuOH fr. to support the medical relevance of this plant.

Methods

The aerial part of S. orientalis was obtained in the mountainous region of Vietnam. The crude ethanol extract (CEE) and its BuOH fr. were prepared from the plant materials. Anti-hyperuricemic activities of the CEE and BuOH fr. were tested in vivo using the model oxonate-induced hyperuricemia rats through determination of serum uric acid levels and inhibitory effects on xanthine oxidase (XO) in the rat liver. Anti-inflammatory activities of the BuOH fr. were also evaluated in vivo using carrageenan-induced paw edema and urate-induced synovitis in rats. Active components of the BuOH fr. were characterized by comparison of HPLC retention time (t R) and spectroscopic data (UV, 1H–NMR) with those of reference compounds.

Results

The CEE of S. orientalis displayed anti-hyperuricemic activity, and the BuOH fr. was found to be the most active portion of the extract. Further in vivo studies on this fraction showed 31.4% decrease of serum uric acid levels, 32.7% inhibition of xanthine oxidase (XO), 30.4% reduction of paw edema volume, symptomatic relief in urate-induced synovitis and significant analgesic effect at the dose of 120 mg/kg, as compared to the corresponding values of the control groups. Chemical analysis of the BuOH fr. revealed high phenolic content, identified as caffeic acid analogues and flavonones.

Conclusions

This study suggested that anti-hyperuricemic and anti-inflammatory mechanism of S. orientalis is related to XO inhibitory effect of the phenolic components. Our findings support the use of this plant as the treatment of gout and other inflammatory diseases.
Appendix
Available only for authorised users
Literature
1.
go back to reference NIMM. (National Institute of Medicinal Materials of Vietnam). Medicinal Plant Resource of Vietnam. Hanoi: Science and Technology Publishing House; 1993. NIMM. (National Institute of Medicinal Materials of Vietnam). Medicinal Plant Resource of Vietnam. Hanoi: Science and Technology Publishing House; 1993.
2.
go back to reference Wang JP, Zhou YM, Ye YJ, Shang XM, Cai YL, Xiong CM, Wu YX, Xu HX. Topical anti-inflammatory and analgesic activity of kirenol isolated from Siegesbeckia orientalis. J Ethnopharmacol. 2011;137:1089–94.CrossRefPubMed Wang JP, Zhou YM, Ye YJ, Shang XM, Cai YL, Xiong CM, Wu YX, Xu HX. Topical anti-inflammatory and analgesic activity of kirenol isolated from Siegesbeckia orientalis. J Ethnopharmacol. 2011;137:1089–94.CrossRefPubMed
3.
go back to reference Do TL. Vietnamese Medicinal Plants and Remedies. Hanoi: Hong Duc Publishing House; 2012. Do TL. Vietnamese Medicinal Plants and Remedies. Hanoi: Hong Duc Publishing House; 2012.
4.
go back to reference Vo VC. The Dictionary of Vietnamese Medicinal Plant. Hochiminh: Medical Publishing House; 2012. Vo VC. The Dictionary of Vietnamese Medicinal Plant. Hochiminh: Medical Publishing House; 2012.
5.
go back to reference Zhang ZF, Yang LR, Li YB, Yan LH. Summary on chemical composition and pharmacological action of Herba Siegesbeckiae. Inf Tradit. Chin. Med. 2006;23:15–7. Zhang ZF, Yang LR, Li YB, Yan LH. Summary on chemical composition and pharmacological action of Herba Siegesbeckiae. Inf Tradit. Chin. Med. 2006;23:15–7.
6.
go back to reference Xiang Y, Zhang H, Fan CQ, Yue JM. Novel diterpenoids and diterpenoid glycosides from Siegesbeckia orientalis. J Nat Prod. 2004;67:1517–21.CrossRefPubMed Xiang Y, Zhang H, Fan CQ, Yue JM. Novel diterpenoids and diterpenoid glycosides from Siegesbeckia orientalis. J Nat Prod. 2004;67:1517–21.CrossRefPubMed
7.
go back to reference Giang PM, Son PT, Otsuka H. ent-pimarane-type diterpenoids from Siegesbeckia orientalis L. Chem Pharm Bull. 2005;53:232–4.CrossRefPubMed Giang PM, Son PT, Otsuka H. ent-pimarane-type diterpenoids from Siegesbeckia orientalis L. Chem Pharm Bull. 2005;53:232–4.CrossRefPubMed
8.
go back to reference Wang F, Cheng XL, Li YJ, Shi S, Liu JK. ent-Pimarane diterpenoids from Siegesbeckia orientalis and structure revision of a related compound. J Nat Prod. 2009;72:2005–8.CrossRefPubMed Wang F, Cheng XL, Li YJ, Shi S, Liu JK. ent-Pimarane diterpenoids from Siegesbeckia orientalis and structure revision of a related compound. J Nat Prod. 2009;72:2005–8.CrossRefPubMed
9.
go back to reference Hong Y-H, Weng L-W, Chang C-C, Hsu H-F, Wang C-P, Wang S-W, Houng J-Y. Anti-inflammatory effects of Siegesbeckia orientalis ethanol extract in in vitro and in vivo models. Biomed Res Int. 2014;2014:329712.PubMedPubMedCentral Hong Y-H, Weng L-W, Chang C-C, Hsu H-F, Wang C-P, Wang S-W, Houng J-Y. Anti-inflammatory effects of Siegesbeckia orientalis ethanol extract in in vitro and in vivo models. Biomed Res Int. 2014;2014:329712.PubMedPubMedCentral
11.
go back to reference Zdero C, Bohlmann F, King RM, Robinson H. Sesquiterpene lactones and other constituents from Siegesbeckia orientalis and Guizotia scabra. Phytochemistry. 1991;30:1579–84.CrossRef Zdero C, Bohlmann F, King RM, Robinson H. Sesquiterpene lactones and other constituents from Siegesbeckia orientalis and Guizotia scabra. Phytochemistry. 1991;30:1579–84.CrossRef
12.
go back to reference Xiang Y, Fan CQ, Yue JM. Novel sesquiterpenoids from Siegesbeckia orientalis. Helv Chim Acta. 2005;88:160–70.CrossRef Xiang Y, Fan CQ, Yue JM. Novel sesquiterpenoids from Siegesbeckia orientalis. Helv Chim Acta. 2005;88:160–70.CrossRef
13.
go back to reference Wang LL, Hu LH. Chemical constituents of Siegesbeckia orientalis L. J Integr Plant Biol. 2006;48:991–5.CrossRef Wang LL, Hu LH. Chemical constituents of Siegesbeckia orientalis L. J Integr Plant Biol. 2006;48:991–5.CrossRef
14.
go back to reference Le TKN. Study on chemical constituents with antioxidant and antimicrobial activities from the Vietnamese plants hy thiem (Siegesbeckia orientalis L.) and bon-bot (Glochidion eriocarpum Champ.). Hanoi: Doctorate thesis, College of Chemistry, Hanoi National University; 2001. Le TKN. Study on chemical constituents with antioxidant and antimicrobial activities from the Vietnamese plants hy thiem (Siegesbeckia orientalis L.) and bon-bot (Glochidion eriocarpum Champ.). Hanoi: Doctorate thesis, College of Chemistry, Hanoi National University; 2001.
15.
go back to reference Masuda T, et al. Identification of a potent xanthine oxidase inhibitor from oxidation of caffeic acid. Free Radic Biol Med. 2010;69:300–7.CrossRef Masuda T, et al. Identification of a potent xanthine oxidase inhibitor from oxidation of caffeic acid. Free Radic Biol Med. 2010;69:300–7.CrossRef
16.
go back to reference Masuoka N, Kubo I. Suppression of superoxide anion generation catalyzed by xanthine oxidase with alkyl caffeates and the scavenging activity. Int J Food Sci Nutr. 2016;67:283–7.CrossRefPubMed Masuoka N, Kubo I. Suppression of superoxide anion generation catalyzed by xanthine oxidase with alkyl caffeates and the scavenging activity. Int J Food Sci Nutr. 2016;67:283–7.CrossRefPubMed
17.
go back to reference Nguyen MT, et al. Xanthine oxidase inhibitory activity of Vietnamese medicinal plants. Biol Pharm Bull. 2004;27:1414–21.CrossRefPubMed Nguyen MT, et al. Xanthine oxidase inhibitory activity of Vietnamese medicinal plants. Biol Pharm Bull. 2004;27:1414–21.CrossRefPubMed
18.
go back to reference Huang J, et al. Effects of Genistein, Apigenin, Quercetin, Rutin and Astilbin on serum uric acid levels and xanthine oxidase activities in normal and hyperuricemic mice. Food and Chem Toxicol. 2011;49:1943–7.CrossRef Huang J, et al. Effects of Genistein, Apigenin, Quercetin, Rutin and Astilbin on serum uric acid levels and xanthine oxidase activities in normal and hyperuricemic mice. Food and Chem Toxicol. 2011;49:1943–7.CrossRef
20.
go back to reference Cao H, Pauff JM, Hille R. X-ray crystal structure of a xanthine oxidase complex with the flavonoid inhibitor quercetin. J Nat Prod. 2014;77:1693–9.CrossRefPubMed Cao H, Pauff JM, Hille R. X-ray crystal structure of a xanthine oxidase complex with the flavonoid inhibitor quercetin. J Nat Prod. 2014;77:1693–9.CrossRefPubMed
21.
go back to reference Zimmermann M. Ethical considerations in relation to pain in animal experimentation. Acta Physiol Scand Suppl. 1986;554:221–33.PubMed Zimmermann M. Ethical considerations in relation to pain in animal experimentation. Acta Physiol Scand Suppl. 1986;554:221–33.PubMed
22.
go back to reference Stavric B, Clayman S, Gadd RE, Hébert D. Some in vivo effects in the rat induced by chlorprothixene and potassium oxonate. Pharmacol Res Commun. 1975;7:117–24.CrossRefPubMed Stavric B, Clayman S, Gadd RE, Hébert D. Some in vivo effects in the rat induced by chlorprothixene and potassium oxonate. Pharmacol Res Commun. 1975;7:117–24.CrossRefPubMed
23.
go back to reference Carroll JJ, Roberta Douglass HC, Babson AL. A simplified alkaline phosphotungstate assay for uric acid in serum. Clin Chem. 1971;17:158–60.PubMed Carroll JJ, Roberta Douglass HC, Babson AL. A simplified alkaline phosphotungstate assay for uric acid in serum. Clin Chem. 1971;17:158–60.PubMed
24.
go back to reference Mo SF, Zhou F, Yao-Zhong LV, Hu QH, Zhang DM, Kong LD. Hypouricemic action of selected flavonoids in mice: Structure-activity relationships. Biol Pharm Bull. 2007;30:1551–6.CrossRefPubMed Mo SF, Zhou F, Yao-Zhong LV, Hu QH, Zhang DM, Kong LD. Hypouricemic action of selected flavonoids in mice: Structure-activity relationships. Biol Pharm Bull. 2007;30:1551–6.CrossRefPubMed
25.
go back to reference Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with folin-phenol reagent. J Biol Chem. 1951;193:265–75.PubMed Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with folin-phenol reagent. J Biol Chem. 1951;193:265–75.PubMed
26.
go back to reference Winter CA, Risley EA, Nuss GW. Carrageenin-induced edema in hind paw of rats as an assay for anti-inflammatory drugs. Proc Soc Exp Biol Med. 1962;111:544–7.CrossRefPubMed Winter CA, Risley EA, Nuss GW. Carrageenin-induced edema in hind paw of rats as an assay for anti-inflammatory drugs. Proc Soc Exp Biol Med. 1962;111:544–7.CrossRefPubMed
27.
go back to reference Walker KM, Urban L, Medhurst SJ, Patel S, Panesar M, Fox AJ, Mcintyre P. The VR1 antagonist capsazepine reverses mechanical hyperalgesia in models of inflammatory and neuropathic pain. J Pharm Experimental Therapeutics. 2003;304:56–62.CrossRef Walker KM, Urban L, Medhurst SJ, Patel S, Panesar M, Fox AJ, Mcintyre P. The VR1 antagonist capsazepine reverses mechanical hyperalgesia in models of inflammatory and neuropathic pain. J Pharm Experimental Therapeutics. 2003;304:56–62.CrossRef
28.
go back to reference Safieh-Garabedian B, Kanaan SA, Haddad JJ, Jaoude PA, Jabbur SJ, Saadé NE. Involvement of interleukin-1ß, nerve growth factor and prostaglandin E2 in endotoxin-induced localized inflammatory hyperalgesia. Br J Pharmacol. 1997;121:1619–26.CrossRefPubMedPubMedCentral Safieh-Garabedian B, Kanaan SA, Haddad JJ, Jaoude PA, Jabbur SJ, Saadé NE. Involvement of interleukin-1ß, nerve growth factor and prostaglandin E2 in endotoxin-induced localized inflammatory hyperalgesia. Br J Pharmacol. 1997;121:1619–26.CrossRefPubMedPubMedCentral
29.
go back to reference Urban L, Campbell EA, Gentry C, Patel S, Chaudry N, James I. Pharmacological profile of SDZ 249–665, a novel capsaicin agonist. Pain. 2000;89:65–74.CrossRefPubMed Urban L, Campbell EA, Gentry C, Patel S, Chaudry N, James I. Pharmacological profile of SDZ 249–665, a novel capsaicin agonist. Pain. 2000;89:65–74.CrossRefPubMed
30.
go back to reference Thuong PT, Su ND, Ngoc TM, Hung TM, Dang NH, Thuan ND, Bae KH, Oh WK. Antioxidant activity and principles of Vietnamese bitter tea Ilex kudingcha. Food Chem. 2009;113:139–45.CrossRef Thuong PT, Su ND, Ngoc TM, Hung TM, Dang NH, Thuan ND, Bae KH, Oh WK. Antioxidant activity and principles of Vietnamese bitter tea Ilex kudingcha. Food Chem. 2009;113:139–45.CrossRef
31.
go back to reference Nguyen MT, Awale S, Tezuka Y, Shi L, Zaidi SF, Ueda JY, Tran QL, Murakami Y, Matsumoto K, Kadota S. Hypouricemic effects of acacetin and 4,5-O-dicaffeoylquinic acid methyl ester on serum uric acid levels in potassium oxonate-pretreated rats. Biol Pharm Bull. 2005;28:2231–4.CrossRefPubMed Nguyen MT, Awale S, Tezuka Y, Shi L, Zaidi SF, Ueda JY, Tran QL, Murakami Y, Matsumoto K, Kadota S. Hypouricemic effects of acacetin and 4,5-O-dicaffeoylquinic acid methyl ester on serum uric acid levels in potassium oxonate-pretreated rats. Biol Pharm Bull. 2005;28:2231–4.CrossRefPubMed
32.
go back to reference Yonathan M, Asres K, Assefa A, Bucar F. In vivo anti-inflammatory and anti-nociceptive activities of Cheilanthes farinosa. J Ethnopharmacol. 2006;108:462–70.CrossRefPubMed Yonathan M, Asres K, Assefa A, Bucar F. In vivo anti-inflammatory and anti-nociceptive activities of Cheilanthes farinosa. J Ethnopharmacol. 2006;108:462–70.CrossRefPubMed
33.
go back to reference Han T, Li HL, Zhang QY, Han P, Zheng HC, Rahman K, Qin LP. Bioactivity-guided fractionation for anti-inflammatory and analgesic properties and constituents of Xanthium strumarium L. Phytomedicine. 2007;14:825–9.CrossRefPubMed Han T, Li HL, Zhang QY, Han P, Zheng HC, Rahman K, Qin LP. Bioactivity-guided fractionation for anti-inflammatory and analgesic properties and constituents of Xanthium strumarium L. Phytomedicine. 2007;14:825–9.CrossRefPubMed
34.
go back to reference Masuda T, Shingai Y, Takahashi C, Inai M, Miura Y, Honda S, Masuda A. Identification of a potent xanthine oxidase inhibitor from oxidation of caffeic acid. Free Radic Biol Med. 2014;69:300–7.CrossRefPubMed Masuda T, Shingai Y, Takahashi C, Inai M, Miura Y, Honda S, Masuda A. Identification of a potent xanthine oxidase inhibitor from oxidation of caffeic acid. Free Radic Biol Med. 2014;69:300–7.CrossRefPubMed
35.
go back to reference Zhu JX, Wang Y, Kong LD, Yang C, Zhang X. Effects of Biota orientalis extract and its flavonoid constituents, quercetin and rutin on serum uric acid levels in oxonate-induced mice and xanthine dehydrogenase and xanthine oxidase activities in mouse liver. J Ethnopharmacol. 2004;93:133–40.CrossRefPubMed Zhu JX, Wang Y, Kong LD, Yang C, Zhang X. Effects of Biota orientalis extract and its flavonoid constituents, quercetin and rutin on serum uric acid levels in oxonate-induced mice and xanthine dehydrogenase and xanthine oxidase activities in mouse liver. J Ethnopharmacol. 2004;93:133–40.CrossRefPubMed
36.
go back to reference Cannella AC, Mikuls TR. Understanding Treatments for Gout. Am J Manag Care. 2005;11(Suppl):S451–8.PubMed Cannella AC, Mikuls TR. Understanding Treatments for Gout. Am J Manag Care. 2005;11(Suppl):S451–8.PubMed
38.
go back to reference Ling X, Bochu WA. A review of phytotherapy of gout: perspective of new pharmacological treatments. Pharmazie. 2014;69:243–56.PubMed Ling X, Bochu WA. A review of phytotherapy of gout: perspective of new pharmacological treatments. Pharmazie. 2014;69:243–56.PubMed
Metadata
Title
Anti-Hyperuricemic, Anti-Inflammatory and Analgesic Effects of Siegesbeckia orientalis L. Resulting from the Fraction with High Phenolic Content
Authors
Thuy Duong Nguyen
Phuong Thien Thuong
In Hyun Hwang
Thi Kim Huyen Hoang
Minh Khoi Nguyen
Hoang Anh Nguyen
MinKyun Na
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Complementary Medicine and Therapies / Issue 1/2017
Electronic ISSN: 2662-7671
DOI
https://doi.org/10.1186/s12906-017-1698-z

Other articles of this Issue 1/2017

BMC Complementary Medicine and Therapies 1/2017 Go to the issue